Pay in 4 interest-free payments of $5.93 Learn more
Ships within 48 hours · Estimated delivery Aug 17 - Aug 22
The doctor will perform an examination, dermoscopy, and if necessary recommend removal of the lesion or a biopsy for an accurate diagnosis
Results typically become visible around week 4 to 6, with significant improvement by month 3
This triple-hormone mechanism is one of the key differences between retatrutide and other medical weight loss peptides currently available, such as semaglutide (a GLP-1 receptor agonist) and tirzepatide (a dual GLP-1 and GIP receptor agonist), and is one reason it has attracted so much attention in clinical obesity research
Mater Adv 6(3):10511066 Funding The authors declare that no funds, grants, or other support were received during the preparation of this manuscript
